European Autism Interventions – A Multicentre Study for Developing New Medications

European Autism Interventions – A Multicentre Study for Developing New Medications (EU-AIMS) – is the largest single grant for autism in the world, and the largest for the study of any mental health disorder in Europe.

EU-AIMS involves a novel collaboration between organisations representing affected individuals and their families (Autism Speaks), academia and Industry who for the first time in the world have come together to develop the infrastructure underpinning new treatments for autism. Patient organizations, academic and industry join forces to develop and assess novel treatment approaches for autism.

Eva Loth, Kings College London, discusses EU-AIMS

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
You have insight(s) remaining for this month. Register for free and view thousands of insights in our archive today. Subscribe for unlimited access.
Copyright © Faculti Media Limited 2022. All rights reserved.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×